메뉴 건너뛰기




Volumn 57, Issue 8, 2013, Pages 4010-4018

Epidemiology and risk factors for isolation of escherichia coli producing ctx-m-type extended-spectrum-lactamase in a large U.S. Medical Center

(32)  Hayakawa, Kayoko a   Gattu, Sureka b   Marchaim, Dror a   Bhargava, Ashish a   Palla, Mohan a   Alshabani, Khaled a   Gudur, Uma Mahesh a   Pulluru, Harish a   Bathina, Pradeep a   Sundaragiri, Pranathi Rao a   Sarkar, Moumita a   Kakarlapudi, Hari a   Ramasamy, Balaji a   Nanjireddy, Priyanka a   Mohin, Shah a   Dasagi, Meenakshi a   Datla, Satya a   Kuchipudi, Vamsi a   Reddy, Swetha a   Shahani, Shobha a   more..


Author keywords

[No Author keywords available]

Indexed keywords

AMIKACIN; AMINOGLYCOSIDE; BACTERIAL ENZYME; CEFEPIME; CEPHALOSPORIN DERIVATIVE; CIPROFLOXACIN; COTRIMOXAZOLE; ERTAPENEM; EXTENDED SPECTRUM BETA LACTAMASE; GENTAMICIN; HISTAMINE H2 RECEPTOR ANTAGONIST; METRONIDAZOLE; NITROFURANTOIN; PENICILLIN DERIVATIVE; PIPERACILLIN PLUS TAZOBACTAM; PROTON PUMP INHIBITOR; SULTAMICILLIN; TETRACYCLINE; TIGECYCLINE; TOBRAMYCIN; VANCOMYCIN;

EID: 84880305418     PISSN: 00664804     EISSN: 10986596     Source Type: Journal    
DOI: 10.1128/AAC.02516-12     Document Type: Article
Times cited : (66)

References (35)
  • 1
    • 84055193439 scopus 로고    scopus 로고
    • Plasmid-mediated resistance in Enterobacteriaceae: Changing landscape and implications for therapy
    • Schultsz C, Geerlings S. 2012. Plasmid-mediated resistance in Enterobacteriaceae: changing landscape and implications for therapy. Drugs 72: 1-16.
    • (2012) Drugs , vol.72 , pp. 1-16
    • Schultsz, C.1    Geerlings, S.2
  • 2
    • 84858597297 scopus 로고    scopus 로고
    • Current trends in culture-based and molecular detection of extended-spectrumbeta-lactamase-harboring and carbapenem-resistant Enterobacteriaceae
    • Gazin M, Paasch F, Goossens H, Malhotra-Kumar S. 2012. Current trends in culture-based and molecular detection of extended-spectrumbeta-lactamase- harboring and carbapenem-resistant Enterobacteriaceae. J. Clin. Microbiol. 50:1140-1146.
    • (2012) J. Clin. Microbiol. , vol.50 , pp. 1140-1146
    • Gazin, M.1    Paasch, F.2    Goossens, H.3    Malhotra-Kumar, S.4
  • 3
    • 80053572626 scopus 로고    scopus 로고
    • Genetic evolution and clinical impact in extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae
    • Chong Y, Ito Y, Kamimura T. 2011. Genetic evolution and clinical impact in extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae. Infect. Genet. Evol. 11:1499-1504.
    • (2011) Infect. Genet. Evol. , vol.11 , pp. 1499-1504
    • Chong, Y.1    Ito, Y.2    Kamimura, T.3
  • 4
    • 39049128343 scopus 로고    scopus 로고
    • Extended-spectrum beta-lactamaseproducing Enterobacteriaceae: An emerging public-health concern
    • Pitout JD, Laupland KB. 2008. Extended-spectrum beta-lactamaseproducing Enterobacteriaceae: an emerging public-health concern. Lancet Infect. Dis. 8:159-166.
    • (2008) Lancet Infect. Dis. , vol.8 , pp. 159-166
    • Pitout, J.D.1    Laupland, K.B.2
  • 5
    • 27144490073 scopus 로고    scopus 로고
    • Extended-spectrum beta-lactamases: A clinical update
    • Paterson DL, Bonomo RA. 2005. Extended-spectrum beta-lactamases: a clinical update. Clin. Microbiol. Rev. 18:657-686.
    • (2005) Clin. Microbiol. Rev. , vol.18 , pp. 657-686
    • Paterson, D.L.1    Bonomo, R.A.2
  • 6
    • 77954879314 scopus 로고    scopus 로고
    • Extended-spectrum betalactamase producing Escherichia coli: Changing epidemiology and clinical impact
    • Oteo J, Perez-Vazquez M, Campos J. 2010. Extended-spectrum betalactamase producing Escherichia coli: changing epidemiology and clinical impact. Curr. Opin. Infect. Dis. 23:320-326.
    • (2010) Curr. Opin. Infect. Dis. , vol.23 , pp. 320-326
    • Oteo, J.1    Perez-Vazquez, M.2    Campos, J.3
  • 9
    • 79960941037 scopus 로고    scopus 로고
    • Cephalosporin and fluoroquinolone combinations are highly associated with CTX-M beta-lactamase-producing Escherichia coli: A case-control study in a French teaching hospital
    • Cassier P, Lallechere S, Aho S, Astruc K, Neuwirth C, Piroth L, Chavanet P. 2011. Cephalosporin and fluoroquinolone combinations are highly associated with CTX-M beta-lactamase-producing Escherichia coli: a case-control study in a French teaching hospital. Clin. Microbiol. Infect. 17:1746-1751.
    • (2011) Clin. Microbiol. Infect. , vol.17 , pp. 1746-1751
    • Cassier, P.1    Lallechere, S.2    Aho, S.3    Astruc, K.4    Neuwirth, C.5    Piroth, L.6    Chavanet, P.7
  • 11
    • 24044511840 scopus 로고    scopus 로고
    • Emergence of Enterobacteriaceae producing extended-spectrum beta-lactamases (ESBLs) in the community
    • Pitout JD, Nordmann P, Laupland KB, Poirel L. 2005. Emergence of Enterobacteriaceae producing extended-spectrum beta-lactamases (ESBLs) in the community. J. Antimicrob. Chemother. 56:52-59.
    • (2005) J. Antimicrob. Chemother. , vol.56 , pp. 52-59
    • Pitout, J.D.1    Nordmann, P.2    Laupland, K.B.3    Poirel, L.4
  • 13
    • 78650339210 scopus 로고    scopus 로고
    • Escherichia coli O25b-ST131: A pandemic, multiresistant, community-associated strain
    • Rogers BA, Sidjabat HE, Paterson DL. 2011. Escherichia coli O25b-ST131: a pandemic, multiresistant, community-associated strain. J. Antimicrob. Chemother. 66:1-14.
    • (2011) J. Antimicrob. Chemother. , vol.66 , pp. 1-14
    • Rogers, B.A.1    Sidjabat, H.E.2    Paterson, D.L.3
  • 16
    • 77953024695 scopus 로고    scopus 로고
    • Molecular characteristics of extended-spectrum beta-lactamase-producing Escherichia coli from the Chicago area: High prevalence of ST131 producing CTX-M-15 in community hospitals
    • Peirano G, Costello M, Pitout JD. 2010. Molecular characteristics of extended-spectrum beta-lactamase-producing Escherichia coli from the Chicago area: high prevalence of ST131 producing CTX-M-15 in community hospitals. Int. J. Antimicrob. Agents 36:19-23.
    • (2010) Int. J. Antimicrob. Agents , vol.36 , pp. 19-23
    • Peirano, G.1    Costello, M.2    Pitout, J.D.3
  • 17
    • 51349130520 scopus 로고    scopus 로고
    • Rapid emergence of blaCTX-M among Enterobacteriaceae in U.S medical centers: Molecular evaluation from the MYSTIC Program (2007)
    • Castanheira M, Mendes RE, Rhomberg PR, Jones RN. 2008. Rapid emergence of blaCTX-M among Enterobacteriaceae in U.S. medical centers: molecular evaluation from the MYSTIC Program (2007). Microb. Drug Resist. 14:211-216.
    • (2008) Microb. Drug Resist. , vol.14 , pp. 211-216
    • Castanheira, M.1    Mendes, R.E.2    Rhomberg, P.R.3    Jones, R.N.4
  • 18
    • 0037097507 scopus 로고    scopus 로고
    • Control-group selection importance in studies of antimicrobial resistance: Examples applied to Pseudomonas aeruginosa, enterococci, and Escherichia coli
    • Harris AD, Samore MH, Lipsitch M, Kaye KS, Perencevich E, Carmeli Y. 2002. Control-group selection importance in studies of antimicrobial resistance: examples applied to Pseudomonas aeruginosa, enterococci, and Escherichia coli. Clin. Infect. Dis. 34:1558-1563.
    • (2002) Clin. Infect. Dis. , vol.34 , pp. 1558-1563
    • Harris, A.D.1    Samore, M.H.2    Lipsitch, M.3    Kaye, K.S.4    Perencevich, E.5    Carmeli, Y.6
  • 19
    • 17444391264 scopus 로고    scopus 로고
    • The case-case-control study design: Addressing the limitations of risk factor studies for antimicrobial resistance
    • Kaye KS, Harris AD, Samore M, Carmeli Y. 2005. The case-case-control study design: addressing the limitations of risk factor studies for antimicrobial resistance. Infect. Control Hosp. Epidemiol. 26:346-351.
    • (2005) Infect. Control Hosp. Epidemiol. , vol.26 , pp. 346-351
    • Kaye, K.S.1    Harris, A.D.2    Samore, M.3    Carmeli, Y.4
  • 20
    • 0023092594 scopus 로고
    • A new method of classifying prognostic comorbidity in longitudinal studies: Development and validation
    • Charlson ME, Pompei P, Ales KL, MacKenzie CR. 1987. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J. Chronic Dis. 40:373-383.
    • (1987) J. Chronic Dis. , vol.40 , pp. 373-383
    • Charlson, M.E.1    Pompei, P.2    Ales, K.L.3    Mackenzie, C.R.4
  • 21
    • 0021857405 scopus 로고
    • Vali-dation of a prognostic score in critically ill patients undergoing transport
    • Bion JF, Edlin SA, Ramsay G, McCabe S, Ledingham IM. 1985. Vali-dation of a prognostic score in critically ill patients undergoing transport. Br. Med. J. 291:432-434.
    • (1985) Br. Med. J. , vol.291 , pp. 432-434
    • Bion, J.F.1    Edlin, S.A.2    Ramsay, G.3    McCabe, S.4    Ledingham, I.M.5
  • 23
    • 44449164571 scopus 로고    scopus 로고
    • CDC/NHSN surveillance definition of health care-associated infection and criteria for specific types of infections in the acute care setting
    • Horan TC, Andrus M, Dudeck MA. 2008. CDC/NHSN surveillance definition of health care-associated infection and criteria for specific types of infections in the acute care setting. Am. J. Infect. Control 36:309-332.
    • (2008) Am. J. Infect. Control , vol.36 , pp. 309-332
    • Horan, T.C.1    Andrus, M.2    Dudeck, M.A.3
  • 26
    • 0035996086 scopus 로고    scopus 로고
    • Identification of PSE and OXA beta-lactamase genes in Pseudomonas aeruginosa using PCRrestriction fragment length polymorphism
    • Bert F, Branger C, Lambert-Zechovsky N. 2002. Identification of PSE and OXA beta-lactamase genes in Pseudomonas aeruginosa using PCRrestriction fragment length polymorphism. J. Antimicrob. Chemother. 50:11-18.
    • (2002) J. Antimicrob. Chemother. , vol.50 , pp. 11-18
    • Bert, F.1    Branger, C.2    Lambert-Zechovsky, N.3
  • 29
    • 78751567921 scopus 로고    scopus 로고
    • Risk factors and outcomes of Escherichia coli bacteremia caused by strains that produce CTX-M or non-CTX-M extended-spectrum-beta-lactamases
    • Wu UI, Wang JL, Chen WC, Chang SC, Chen YC. 2011. Risk factors and outcomes of Escherichia coli bacteremia caused by strains that produce CTX-M or non-CTX-M extended-spectrum-beta-lactamases. Eur. J. Clin. Microbiol. Infect. Dis. 30:33-39.
    • (2011) Eur. J. Clin. Microbiol. Infect. Dis. , vol.30 , pp. 33-39
    • Wu, U.I.1    Wang, J.L.2    Chen, W.C.3    Chang, S.C.4    Chen, Y.C.5
  • 33
    • 74549120901 scopus 로고    scopus 로고
    • Risk factors for extended-spectrum beta-lactamase positivity in uropathogenic Escherichia coli isolated from community-acquired urinary tract infections
    • Azap OK, Arslan H, Serefhanoglu K, Colakoglu S, Erdogan H, Timurkaynak F, Senger SS. 2010. Risk factors for extended-spectrum beta-lactamase positivity in uropathogenic Escherichia coli isolated from community-acquired urinary tract infections. Clin. Microbiol. Infect. 16:147-151.
    • (2010) Clin. Microbiol. Infect. , vol.16 , pp. 147-151
    • Azap, O.K.1    Arslan, H.2    Serefhanoglu, K.3    Colakoglu, S.4    Erdogan, H.5    Timurkaynak, F.6    Senger, S.S.7


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.